Global Atrophie Biomarker Evaluation Study (GABiE)

NCT03935126 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2021-05-21

Study results available
· View outcomes & findings →

Summary

To investigate the use of microperimetry and SS-OCT in assessing the natural changes of retinal sensitivity and anatomy in the perilesional zone of geographic atrophy areas in patients with dry age-related macular degeneration.

Conditions

  • Age-related Macular Degeneration

Interventions

DIAGNOSTIC_TEST

Diagnostics

Diagnostics

Sponsors & Collaborators

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-07
Primary Completion
2020-05-06
Completion
2020-05-14

Countries

  • United States
  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03935126 on ClinicalTrials.gov